Though coming as a surprise to many people, research shows that some nightmares can be treatable. People with PTSD are often prescribed a drug called prazosin. Long used to treat high blood pressure, the medication also reduces nightmares in some patients with PTSD-associated nightmares, though studies of its efficacy are somewhat mixed, Youngren said. “And when the medication is stopped, nightmares come back. So, it’s not a long-term treatment,” he added.
Instead, many psychologists have embraced psychological interventions, with the hopes that they will have more staying power. Such interventions include image rehearsal therapy (IRT) and closely related offshoots such as exposure, relaxation, and rescripting therapy (ERRT). Known collectively as “rescripting” therapies, IRT and ERRT involve helping a patient rewrite the narrative in their nightmare to make it less distressing. With a clinician’s help, patients write the new version and review it each day before bed, with the idea that the rescripted story will replace the traumatic nightmare. The goal is not necessarily to give the nightmare a happy ending but to alter the dream enough to make it more tolerable. “A person who saw their friend get killed might rescript it so they’re able to go to their friend and tell him they love him before he died,” Youngren explained.
The American Academy of Sleep Medicine recommends IRT for treating PTSD-associated nightmares and nightmare disorder, while prazosin and other medications “may be used” for PTSD-associated nightmares—a position indicating that the available evidence is less clear (Morgenthaler, T. I., et al., Journal of Clinical Sleep Medicine, Vol. 14, No. 6, 2018opens in new window). “Imagery rehearsal therapies have been used with all kinds of populations, from adult trauma victims to children,” Zadra said. “They are the best tools available at this point, and I think they’ll remain the best tools because they’re effective in a majority of people with nightmares, including trauma-related and [nontraumatic] chronic nightmares.”
While IRT lends itself most easily to recurrent nightmares such as those common in PTSD, it can also benefit people with nontraumatic nightmares. Those with nightmare disorder often have similar themes that show up repeatedly, Zadra noted. Even when nightmares differ from night to night, the act of rescripting them can help people begin to feel they have gained mastery over their dreams. “People feel they’re no longer helpless, and that can lead to different outcomes in future nightmares,” he said. “Next time, you don’t drive off a cliff or get caught by the monster.”
Psychologists can teach patients IRT in three or four sessions, but research suggests even one or two short sessions can have benefits. In a small study conducted during the Covid-19 pandemic, Schredl treated people with nightmares using a single telephone counseling session that included a brief version of IRT. The participants then continued to practice the technique on their own over the following weeks. Schredl found that the single session significantly reduced nightmare frequency in 64% of participants and lessened nightmare distress in 63% (Somnologie, Vol. 25, No. 3, 2021opens in new window).
Still, rescripting therapies are not a slam dunk. A meta-analysis of IRT for posttraumatic nightmares found that the intervention resulted in small to moderate effects on nightmare frequency, sleep quality, and PTSD symptoms (Yücel, D. E., et al., Sleep Medicine Reviews, Vol. 50, No. 101248, 2020opens in new window). “There’s a lot of room to grow. As a researcher, I find it fascinating to ask how we can make IRT better,” Youngren said.
With that in mind, he and his colleagues are exploring a paradigm known as targeted dream incubation. The intervention involves giving people verbal stimuli as they are falling asleep, with the goal of influencing the content in their dreams. Youngren is interested in whether dream incubation could work in concert with IRT, and he is conducting a pilot study to test the feasibility of dream incubation in trauma survivors. “We’ve seen that people who do targeted dream incubation often find they have more control of their dreams. That’s important, since many people who experience nightmares talk about dreams as something that just happens to them, rather than something they can control,” he said.
Other researchers have taken an interest in lucid dreaming. A lucid dream is one in which the person realizes they are asleep and dreaming, a phenomenon movie buffs might recognize from the film Inception. In theory, knowing the monster you are facing is not real could take the edge off a formidable nightmare. Lucid dreaming could work well in concert with IRT to help people gain a sense of control over the events in their dreams, Schredl said. Yet estimates indicate that only about 55% of people experience lucid dreams in their lifetimes, and fewer than a quarter have lucid dreams on at least a monthly basis (Saunders, D. T., et al., Consciousness and Cognition, Vol. 43, 2016opens in new window). Though people can learn to lucid dream, mastering the skill can be difficult. And it is too soon to say how it might help people rewrite the imagery in their nightmares for the better, Schredl said. “Just knowing that you’re dreaming doesn’t necessarily give you the control to change what’s happening,” he said.
While scientists continue to hone interventions for nightmare disorder, they are eager to spread the word that current rescripting treatments do help some people. Those with and without PTSD often have no idea that something can be done about their nightmares, and few even mention their nightmares to health care providers (Nadorff, M. R., et al., Journal of Clinical Sleep Medicine, Vol. 11, No. 7, 2015opens in new window). Many clinicians are equally unaware. “For some time, our views on dreaming have been kind of outdated,” Youngren said. “When a client comes into the clinic, we’re really good at checking to see if they’re anxious or depressed or suicidal, but we still wrongly think of dreaming and nightmares as this other thing that’s not as important.”
That’s not surprising, since clinical training programs typically give scant if any attention to dreams and nightmares. In part, that may be because dreams do not lend themselves easily to research or clinical trials. They happen unpredictably and exist completely inside someone’s unconscious brain. “Nightmares are difficult to trap in a lab,” Kelly said. But that could be changing.
Scientists are applying more cognitive neuroscientific perspectives to dreams and nightmares, and new work on lucid dreaming and targeted dream incubation offers the tantalizing possibility that researchers could probe dreams in real time, Stickgold said. “We’re coming closer to real experimental research on dreaming,” he added. “I believe we’re on the cusp of a real explosion of dream research.”